Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
Lexicon Pharmaceuticals (Nasdaq: LXRX) has scheduled its second quarter 2025 financial results release for Wednesday, August 6, 2025, before the market opens. The company will host a conference call and webcast at 8:30 a.m. ET (7:30 a.m. CT) on the same day.
Management will present the financial results and provide a business update during the call. Investors can access the live webcast through the Events page on Lexicon's investor relations website, and those wishing to ask questions can register to receive dial-in information.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per mercoledì 6 agosto 2025, prima dell'apertura del mercato. La società terrà una conference call e una trasmissione in webcast alle 8:30 a.m. ET (7:30 a.m. CT) dello stesso giorno.
La direzione presenterà i risultati finanziari e fornirà un aggiornamento sull’andamento aziendale durante la chiamata. Gli investitori possono seguire la diretta webcast tramite la pagina Eventi del sito dedicato agli investitori di Lexicon, e chi desidera porre domande può registrarsi per ricevere le informazioni per il collegamento telefonico.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el miércoles 6 de agosto de 2025, antes de la apertura del mercado. La compañía realizará una llamada de conferencia y una transmisión por webcast a las 8:30 a.m. ET (7:30 a.m. CT) ese mismo día.
La dirección presentará los resultados financieros y ofrecerá una actualización del negocio durante la llamada. Los inversores pueden acceder a la transmisión en vivo a través de la página de Eventos en el sitio web de relaciones con inversores de Lexicon, y quienes deseen hacer preguntas pueden registrarse para recibir la información de acceso telefónico.
Lexicon Pharmaceuticals (Nasdaq: LXRX)는 2025년 2분기 재무 실적 발표를 2025년 8월 6일 수요일 시장 개장 전으로 예정했습니다. 회사는 같은 날 동부 시간 오전 8:30 (중부 시간 오전 7:30)에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
경영진은 콜에서 재무 실적을 발표하고 사업 현황을 업데이트할 것입니다. 투자자들은 Lexicon 투자자 관계 웹사이트의 이벤트 페이지를 통해 라이브 웹캐스트에 접속할 수 있으며, 질문을 원하는 경우 전화 접속 정보를 받기 위해 등록할 수 있습니다.
Lexicon Pharmaceuticals (Nasdaq : LXRX) a programmé la publication de ses résultats financiers du deuxième trimestre 2025 pour le mercredi 6 août 2025, avant l’ouverture des marchés. La société tiendra une conférence téléphonique et un webcast à 8h30 ET (7h30 CT) le même jour.
La direction présentera les résultats financiers et fournira une mise à jour commerciale lors de l’appel. Les investisseurs peuvent accéder au webcast en direct via la page Événements du site des relations investisseurs de Lexicon, et ceux qui souhaitent poser des questions peuvent s’inscrire pour recevoir les informations d’accès téléphonique.
Lexicon Pharmaceuticals (Nasdaq: LXRX) hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Mittwoch, den 6. August 2025, vor Markteröffnung, angesetzt. Das Unternehmen wird am selben Tag eine Telefonkonferenz und eine Webcast um 8:30 Uhr ET (7:30 Uhr CT) abhalten.
Das Management wird während des Anrufs die Finanzergebnisse vorstellen und ein Geschäft-Update geben. Investoren können den Live-Webcast über die Veranstaltungsseite auf der Investor-Relations-Website von Lexicon verfolgen, und wer Fragen stellen möchte, kann sich registrieren, um die Einwahlinformationen zu erhalten.
- None.
- None.
THE WOODLANDS, Texas, July 23, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its second quarter 2025 financial results on Wednesday, August 6, 2025, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
When will Lexicon Pharmaceuticals (LXRX) report Q2 2025 earnings?
What time is Lexicon's Q2 2025 earnings conference call?
How can investors access Lexicon Pharmaceuticals' Q2 2025 earnings call?
Will Lexicon's Q2 2025 earnings call be available for replay?
